)
Investor Relations14 Oct 2025
Boost Your Earnings Season Strategy With Real‑Time Alerts
Quartr Pro provides real time alerts, trend analysis and live coverage, giving analysts and investors instant insights to act faster in earnings.
Forte Biosciences (FBRX) investor relations material
Forte Biosciences Q2 2025 earnings summary
Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.Q2 2025 earnings summary14 Aug, 2025
Executive summary
Lead candidate FB102 advanced with positive Phase 1b celiac disease data; Phase 2 celiac and Phase 1b vitiligo trials underway, alopecia areata trial initiated, topline data expected in 2026.
$106.1 million in cash and cash equivalents as of June 30, 2025, expected to fund operations for at least 12 months.
Closed $75 million public offering in June 2025 and $53 million private placement in November 2024, strengthening liquidity.
No revenue generated; focus remains on clinical development of FB102 for autoimmune indications.
Financial highlights
Net loss of $11.2 million for Q2 2025, improved from $12.5 million in Q2 2024; net loss of $26.9 million for six months ended June 30, 2025, up from $19.9 million year-over-year.
Research and development expenses rose to $8.6 million in Q2 2025 from $5.7 million in Q2 2024, driven by clinical trial activity.
General and administrative expenses decreased to $3.0 million in Q2 2025 from $7.1 million in Q2 2024, mainly due to lower legal and professional fees.
Cash used in operating activities was $20.4 million for the six months ended June 30, 2025; net cash provided by financing activities was $68.0 million.
Outlook and guidance
Cash runway expected to last at least 12 months from filing date; additional capital will be needed to complete FB102 development.
Topline data from Phase 2 celiac and Phase 1b vitiligo trials anticipated in 2026; alopecia areata trial also underway.
Future capital requirements depend on clinical progress, regulatory outcomes, and potential strategic partnerships.
Assess FB102's competitive advantages.
Evaluate OBBBA's impact on financials.
Detail FB102's autoimmune applications.
Partial view of Summaries dataset, powered by Quartr API
Research faster. Power your platform.
Next Forte Biosciences earnings date
Q3 202511 Nov, 2025
Next Forte Biosciences earnings date
Q3 202511 Nov, 2025
The essential earnings season companion
The #1 app for live earnings calls, transcripts, analyst estimates, and more. All for free.
Live calls and transcripts
Listen to earnings calls, CMDs, investor conferences, and more – with a podcast-like experience.
Find what you need faster
Search for any keyword across all transcripts simultaneously.
Easily store key findings
Capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Your watchlist. Your dashboard.
Follow the companies that matter to you. Get a personalized feed with real-time updates.
Be the first to know
Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned.
Consensus estimates
Access analyst consensus estimates, valuation multiples, and revenue segments splits.
All IR material in one place
The easiest way to stay updated during earnings season.
Global coverage
All events from public companies. Live and recorded.
Just click and listen
No webcast links. No manual registrations.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
)
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
)
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
anuj283App Store
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
anuj283App Store
I can't remember the last time an app had such a positive impact on my investment process.
)
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
@theshortbearx.com
I can't remember the last time an app had such a positive impact on my investment process.
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
@theshortbearx.com
Related articles
)
Edge3 Oct 2025
Epiroc: A Culture of Moving Mountains
From automation to electrification, Swedish industrial giant Epiroc is leading a transformation in how the world mines.
)
Company Research22 Sep 2025
Moody's: Shaping Global Credit
Explore Moody's evolution from publishing manuals to becoming a giant in credit ratings, guiding issuers, investors, and regulators worldwide.
Frequently asked questions
Forte Biosciences Inc is a clinical-stage biopharmaceutical company focused on developing therapies for autoimmune diseases and inflammatory skin conditions. The company is engaged in the research and development of new treatments targeting unmet medical needs. Forte Biosciences operates within the healthcare and biotechnology sectors. The company is headquartered in Dallas, Texas, and its shares are listed on the NASDAQ.
Quartr provides global coverage of all investor relation material from public companies.
Mobile app: Research anytime, anywhere with the #1 app for live earnings calls, transcripts, analyst estimates, and more. All for free.
Desktop (Quartr Pro): The leading platform for qualitative research, used daily by top firms and financial institutions.
Quartr API: Build custom solutions powered by live earnings calls, live transcripts, filings and reports, slide presentations, and more.
Yes, the Quartr mobile app is free on both iOS and Android.
Yes. Quartr provides global, industry-leading live coverage of company events such as regular earnings calls, capital markets days, M&A announcements, and investor conferences. Live with zero delays. Just click and listen.
Yes, capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Yes. Follow the companies that matter to you. Get a personalized feed with real-time updates, a tailored earnings calendar, and instant alerts when earnings calls go live.
Yes. Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned, regardless of who's talking.
Explore our global coverage